About ViroVet
ViroVet is a company based in Leuven (Belgium) founded in 2015.. ViroVet has raised $13.63 million across 3 funding rounds from investors including PMV, Aratana and Capricorn Partners. The company has 14 employees as of December 31, 2022. ViroVet offers products and services including PLLAV Vaccines and Antiviral Drugs. ViroVet operates in a competitive market with competitors including Merck Animal Health, TARGAN, VitamFero, Intervacc and Pacific GeneTech, among others.
- Headquarter Leuven, Belgium
- Employees 14 as on 31 Dec, 2022
-
Sectors
Agriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Virovet Nv
-
Annual Revenue
$14.97 K (USD)-88as on Dec 31, 2021
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.63 M (USD)
in 3 rounds
-
Latest Funding Round
$6.6 M (USD), Series B
May 28, 2020
-
Investors
PMV
& 6 more
-
Employee Count
14
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ViroVet
ViroVet offers a comprehensive portfolio of products and services, including PLLAV Vaccines and Antiviral Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative vaccines for viral infections in swine without cold chain.
Fast-acting treatments for respiratory diseases in livestock.
Unlock access to complete
Unlock access to complete
Funding Insights of ViroVet
ViroVet has successfully raised a total of $13.63M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.6 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $6.6M
-
First Round
First Round
(10 Jan 2017)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Series B - ViroVet | Valuation | Seventure Partners | |
| Oct, 2017 | Amount | Series A - ViroVet | Valuation | Capricorn Partners |
|
| Jan, 2017 | Amount | Series A - ViroVet | Valuation | PMV |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ViroVet
ViroVet has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include PMV, Aratana and Capricorn Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
Investments are directed by Capricorn Partners into European tech ventures.
|
Founded Year | Domain | Location | |
|
Investments are made in sustainable agriculture and agribusiness.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ViroVet
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ViroVet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Virovet Comparisons
Competitors of ViroVet
ViroVet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, VitamFero, Intervacc and Pacific GeneTech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccine technology is developed and supplied for livestock animals.
|
|
| domain | founded_year | HQ Location |
Automated targeted vaccine systems for livestock and aquaculture are developed.
|
|
| domain | founded_year | HQ Location |
Offers patented immunostimulating vaccines for livestock.
|
|
| domain | founded_year | HQ Location |
Recombinant vaccines for cattle, equine, and other livestock are developed.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines and gene delivery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Virovet
Frequently Asked Questions about ViroVet
When was ViroVet founded?
ViroVet was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is ViroVet located?
ViroVet is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Is ViroVet a funded company?
ViroVet is a funded company, having raised a total of $13.63M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5.27M, raised on Jan 10, 2017.
How many employees does ViroVet have?
As of Dec 31, 2022, the latest employee count at ViroVet is 14.
What is the annual revenue of ViroVet?
Annual revenue of ViroVet is $14.97K as on Dec 31, 2021.
What does ViroVet do?
Virovet is a biopharmaceutical company engaged in the manufacturing and supply of antiviral drugs for livestock animals catering to the domestic as well as international markets. Its solutions can be used alone or in combination with vaccines to prevent or treat endemic and epizootic viral diseases. The company is using a technology platform to develop a modified live virus (MLV) vaccines. It is also developing antiviral drugs to control and treat respiratory diseases of cattle and swine.
Who are the top competitors of ViroVet?
ViroVet's top competitors include TARGAN, Merck Animal Health and Intervacc.
What products or services does ViroVet offer?
ViroVet offers PLLAV Vaccines and Antiviral Drugs.
Who are ViroVet's investors?
ViroVet has 7 investors. Key investors include PMV, Aratana, Capricorn Partners, flanders.bio, and Seventure Partners.